Alpha emitters for cancer treatment

Our vision

Thor Medical  will become the world leading supplier of alpha emitters for cancer therapy

About Thor Medical

Thor Medical is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium (Th-232).

The production process is based on a novel technology developed by Thor Medical that combines high efficiency and cost competitive structure with best in class environmental friendliness.

Read more

Alpha emitters for cancer treatment

Radionuclide Therapy (RNT) or Radioligand Therapy (RLT) utilising alpha-particle emitters is a promising technology for cancer treatment with a strong growth.

Read more



Investor relation

We are committed to provide all shareholders and potential investors with relevant financial information in a consistent and transparent manner. Here you will find relevant information about Thor Medical.

Sign up to news

Privacy statement

This service is operated by Investis Digital on behalf of Thor Medical. Investis Limited registered office is 24 Fashion Street, London, E1 6PX.

Full name

Thank you!
Your submission has been received!

Oops! Something went wrong. Try again later.